Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;334:484-485 (10 March), doi:10.1136/bmj.39134.625012.80
Evidence so far is promising, yet the optimal programme is unclear
| The first 150 words of the full text of this article appear below. |
The benefits of exercise in people with cardiovascular disease are well documented,1 but its effect in people with cancer is less well studied. This is largely because research into the effects of exercise in preventing and recovering from heart attacks and strokes has been studied for much longer.
In this week's BMJ, a randomised controlled trial by Mutrie and colleagues assesses the functional and psychological effects of a 12 week exercise programme in women with early stage breast cancer.2 It found no significant difference in the primary outcome of quality of life at 12 weeks as measured by the functional assessment of cancer therapy (FACT-G) questionnaire. However, it did find significant improvements at 12 weeks in secondary outcomes such as the number of metres walked in 12 minutes, the amount of exercise of moderate intensity taken in one week, mobility of the shoulder, and breast cancer specific quality of
Julie K Silver, assistant professor
Harvard Medical School, Framingham, MA 01702, USA
jksilver@bics.bwh.harvard.edu